ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP) (TITAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01151423
Recruitment Status : Completed
First Posted : June 28, 2010
Last Update Posted : August 11, 2015
Sponsor:
Information provided by (Responsible Party):
Ablynx